Provectus Biopharmaceuticals Inc (PVCT) Financial Statements (2023 and Earlier)

Company Profile

Business Address 10025 INVESTMENT DRIVE
KNOXVILLE, TN 37932
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments68397591511061,16614,179
Cash and cash equivalents68397591511061,16614,179
Restricted cash and investments2,424      
Receivables5 55    
Prepaid expense330323350370400  
Other current assets     36141
Other undisclosed current assets 4 595452300500
Total current assets:3,4424249961,0179581,82614,720
Noncurrent Assets
Operating lease, right-of-use asset40121194
Property, plant and equipment32455872877285
Intangible assets, net (including goodwill) (11,715)2288991,5702,2412,913
Intangible assets, net (excluding goodwill) (11,715)2288991,5702,2412,913
Other noncurrent assets      27
Other undisclosed noncurrent assets 11,715  8211,4712,695
Total noncurrent assets:711664819722,4783,7855,720
TOTAL ASSETS:3,5135891,4771,9883,4365,61120,440
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,3015,2332,4464,1023,9992,1424,123
Accounts payable1,2879571,1263,3123,2711,9201,887
Accrued liabilities2,0021,5011,255790729222386
Interest and dividends payable112,77565    
Settlement liabilities      1,850
Debt1,26016,622576    
Due to related parties2006,770     
Other undisclosed current liabilities2,9402,087     
Total current liabilities:7,70130,7123,0234,1023,9992,1424,123
Noncurrent Liabilities
Long-term debt and lease obligation 4513,12813,932   
Long-term debt, excluding current maturities  12,99713,932   
Operating lease, liability 45131
Liabilities, other than long-term debt  1,227712   
Due to related parties  1,227712   
Other undisclosed noncurrent liabilities (6)8,1726599,456  
Total noncurrent liabilities: 8422,52615,3039,456  
Total liabilities:7,70130,79625,54919,40613,4552,1424,123
Stockholders' equity
Stockholders' equity attributable to parent, including:(4,187)(30,206)(24,072)(17,417)(10,019)3,46916,317
Preferred stock     0 
Common stock419399390385371365205
Additional paid in capital241,440209,923209,379209,092208,351208,328196,908
Accumulated other comprehensive loss(34)(34)(24)    
Accumulated deficit(246,034)(240,494)(233,817)(226,894)(218,741)(205,223)(180,796)
Other undisclosed stockholders' equity attributable to parent22      
Total stockholders' equity:(4,187)(30,206)(24,072)(17,417)(10,019)3,46916,317
TOTAL LIABILITIES AND EQUITY:3,5135891,4771,9883,4365,61120,440

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Operating expenses(4,672)(4,964)(6,300)(8,054)(13,721)(24,512)(24,654)
Operating loss:(4,672)(4,964)(6,300)(8,054)(13,721)(24,512)(24,654)
Nonoperating income (expense)(867)(1,714)23203125
Investment income, nonoperating0323203125
Interest and debt expense63(1,748)(1,455)(970)   
Loss from continuing operations before equity method investments, income taxes:(5,476)(8,426)(7,732)(9,004)(13,690)(24,510)(24,649)
Other undisclosed income (loss) from continuing operations before income taxes(63)7,748809851   
Loss from continuing operations before income taxes:(5,540)(678)(6,923)(8,153)(13,690)(24,510)(24,649)
Income tax expense (benefit)(736)(276)1,6951,724   
Net loss:(6,275)(953)(5,228)(6,429)(13,690)(24,510)(24,649)
Other undisclosed net income (loss) attributable to parent736(5,724)(1,695)(1,724)17283147
Net loss attributable to parent:(5,540)(6,678)(6,923)(8,153)(13,518)(24,427)(24,502)
Other undisclosed net loss available to common stockholders, basic    (14)(4,432) 
Net loss available to common stockholders, diluted:(5,540)(6,678)(6,923)(8,153)(13,532)(28,860)(24,502)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(6,275)(953)(5,228)(6,429)(13,690)(24,510)(24,649)
Other comprehensive loss(0)(10)(24)    
Comprehensive loss:(6,275)(963)(5,252)(6,429)(13,690)(24,510)(24,649)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent736(5,724)(1,695)    
Comprehensive loss, net of tax, attributable to parent:(5,540)(6,688)(6,947)(6,429)(13,690)(24,510)(24,649)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: